A note on this column: This article is general medical information, not a description of a service offered at this practice. Dr. Ishiguro's surgical practice is focused on hip and knee conditions — he does not treat or perform surgery for lumbar spinal stenosis or other spinal disorders. This column is written to help readers understand a common condition and know when and how to seek the right specialist, typically a spine-focused orthopaedic surgeon, neurosurgeon, or physiatrist.
What lumbar spinal stenosis actually is
The lumbar spinal canal is a bony tunnel running through the lower vertebrae that houses the nerve roots supplying the legs and pelvis. Lumbar spinal stenosis (LSS) is a narrowing of this canal — or of the smaller side channels (the neural foramina and lateral recesses) through which individual nerve roots exit — that compresses the nerves and the blood vessels feeding them.
Degenerative LSS, the type seen in the large majority of adults, develops gradually as several age-related changes compound one another: intervertebral discs lose height and bulge backward, the facet joints thicken and develop osteoarthritic bone spurs, and the ligamentum flavum — a band of tissue lining the back of the canal — thickens and buckles inward. Any of these changes alone may cause little trouble; together, over years, they can narrow the canal enough to compress the nerves within it. A forward slip of one vertebra over another (degenerative spondylolisthesis) commonly contributes as well. A smaller number of people have a congenitally narrow canal that makes them symptomatic at a younger age with less degenerative change.
How common it is
Estimates of prevalence vary considerably depending on whether stenosis is defined by symptoms, imaging, or both, and by the population studied.
What the evidence shows: A 2020 systematic review and meta-analysis of 41 studies found the mean prevalence of clinically diagnosed LSS was 11% (95% CI 4–18%) in general populations, rising to 25–29% among patients presenting to primary or secondary care (Jensen et al., Eur Spine J, 2020). In Japan specifically, the population-based Wakayama Spine Study of 1,009 adults found a 9.3% prevalence of symptomatic LSS (95% CI 7.7–11.3%), with similar rates in men and women, and prevalence increasing markedly with age (Ishimoto et al., Osteoarthritis Cartilage, 2012).
LSS is now recognised as the most common reason for spine surgery in adults over 65, reflecting both the aging of the population and the tendency of degenerative changes to accumulate over decades.
Neurogenic claudication — the hallmark symptom
The classic presentation of LSS is neurogenic claudication: pain, heaviness, numbness, or tingling in the buttocks and legs that comes on with standing or walking and eases with sitting or leaning forward. Bending forward — flexing the lumbar spine — opens up the canal slightly and often relieves symptoms, which is why patients with LSS often report that walking uphill (which involves a forward-leaning posture) is easier than walking downhill, and why many instinctively lean on a shopping cart or bicycle handlebars for relief, sometimes called the "shopping cart sign."
Because this pattern can resemble poor circulation in the legs, distinguishing neurogenic from vascular claudication is an important early step in evaluation.
| Feature | Neurogenic claudication (LSS) | Vascular claudication (PAD) |
|---|---|---|
| Trigger | Standing or walking, worse with spinal extension | Walking distance, regardless of posture |
| Relief | Sitting or bending forward, even without stopping | Simply stopping and standing still |
| Uphill vs. downhill | Uphill often easier (forward-flexed posture) | Uphill typically harder (more muscular demand) |
| Pulses / skin | Usually normal | Diminished pulses, cool skin, hair loss possible |
| Cycling | Often tolerated well (spine flexed while seated) | Can still provoke symptoms |
Muscle strength is often preserved on examination even when symptoms are significant, though focal weakness, reduced reflexes, or sensory changes in a specific nerve root distribution can be present. Symptoms are frequently bilateral and asymmetric, unlike a single herniated disc, which more often produces one-sided sciatica.
How the diagnosis is made
LSS is a clinical diagnosis supported by imaging, not an imaging diagnosis on its own. A careful history — the pattern of symptoms with walking and posture, distance walked before symptoms start, and what provides relief — combined with a physical examination remains central. MRI without contrast is the imaging study of choice, as it directly visualises the soft-tissue and bony structures narrowing the canal and helps rule out other causes of leg pain, such as a herniated disc, hip arthritis, or a peripheral nerve problem. CT myelography is reserved for patients who cannot undergo MRI.
An important caveat: Imaging findings of canal narrowing are extremely common in older adults without any symptoms at all, and the degree of narrowing seen on a scan correlates only loosely with the severity of a patient's symptoms. This is why treatment decisions should always be guided primarily by the clinical picture — how much the condition is actually limiting a patient's walking and daily life — rather than by imaging appearance alone.
What the evidence says about treatment
Most patients with LSS are managed non-surgically at first, and treatment intensity generally tracks how much walking tolerance and quality of life have been affected.
Commonly used treatment options
- Activity modification and education — understanding the flexion-relief pattern helps patients pace activity and choose postures (such as a slight forward lean, or using a rollator/cart) that extend walking tolerance
- Physical therapy and structured exercise — flexion-biased strengthening, aerobic conditioning (often cycling, which is well tolerated), and general fitness work
- Weight management and treatment of comorbidities — relevant given the older population typically affected
- Medications — used cautiously in older adults; evidence for standard analgesics and neuropathic agents in LSS specifically is limited, and NSAIDs and opioids carry particular risks in this age group
- Epidural steroid injections — widely used, though rigorous trial evidence for lasting benefit is limited (see below)
- Interspinous spacer devices — a minimally invasive implant placed between adjacent spinous processes to hold the segment in slight flexion, an option for select patients between conservative care and open decompression
- Surgical decompression (laminectomy, with or without fusion) — considered when walking tolerance and quality of life remain significantly limited despite a genuine trial of conservative care
The comparative effectiveness of surgery versus non-surgical care has been studied more rigorously for LSS than for many other spinal conditions.
What the evidence shows: The Spine Patient Outcomes Research Trial (SPORT), a large multicenter study combining randomized and observational cohorts, followed patients with LSS for up to four years and found that those treated surgically showed significantly greater improvement in pain, function, and satisfaction compared with those managed non-surgically, with the advantage for surgery persisting through the follow-up period (Weinstein et al., N Engl J Med, 2008).
More recent work, however, suggests that a well-structured non-surgical program can close much of that gap for appropriately selected patients.
What the evidence shows: A randomized trial of 169 surgical candidates with LSS aged 50 and older assigned patients to either surgical decompression or a structured physical therapy program. At two years, physical function scores were statistically similar between the two groups, even though roughly a third of the PT group had crossed over to surgery by that point. The authors concluded that a structured PT program produces outcomes similar to surgery for many patients willing to try it first (Delitto et al., Ann Intern Med, 2015).
Taken together, the SPORT and Delitto trials are not contradictory so much as complementary: surgery offers a reliable and durable benefit for patients who choose it, while a genuine trial of structured non-surgical care is a reasonable and evidence-supported first step for many patients, with surgery remaining available if symptoms don't improve.
Epidural steroid injections deserve a specific mention, since they remain one of the most frequently used treatments for LSS despite mixed trial evidence.
What the evidence shows: A double-blind, multicenter randomized trial of 400 patients with LSS and moderate-to-severe leg pain compared epidural injection of glucocorticoid plus lidocaine against lidocaine alone. At six weeks, the steroid-containing injection offered minimal or no additional benefit over anesthetic alone, with no significant difference regardless of injection technique (interlaminar vs. transforaminal) (Friedly et al., N Engl J Med, 2014). This doesn't mean injections have no role — some patients do get meaningful short-term relief that can help them progress with physical therapy — but it argues against relying on repeated steroid injections as a stand-alone long-term strategy.
When to see a specialist — and when it's urgent
Gradually worsening walking tolerance from typical neurogenic claudication is not an emergency, but it is worth a proper evaluation once it starts limiting daily activity, both to confirm the diagnosis and to rule out other causes of leg symptoms in older adults, including vascular disease and hip arthritis. A small number of presentations, however, need urgent attention: new bladder or bowel dysfunction, saddle-area numbness, or rapidly progressive leg weakness can indicate cauda equina syndrome, a surgical emergency that requires immediate care rather than a routine outpatient referral.
References (PubMed / Journal)
Jensen RK, Jensen TS, Koes B, Hartvigsen J. Prevalence of lumbar spinal stenosis in general and clinical populations: a systematic review and meta-analysis. Eur Spine J. 2020;29(9):2143–2163. DOI: 10.1007/s00586-020-06339-1
Ishimoto Y, Yoshimura N, Muraki S, et al. Prevalence of symptomatic lumbar spinal stenosis and its association with physical performance in a population-based cohort in Japan: the Wakayama Spine Study. Osteoarthritis Cartilage. 2012;20(10):1103–1108. DOI: 10.1016/j.joca.2012.06.018
Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical versus nonsurgical therapy for lumbar spinal stenosis. N Engl J Med. 2008;358(8):794–810. DOI: 10.1056/NEJMoa0707136
Delitto A, Piva SR, Moore CG, et al. Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial. Ann Intern Med. 2015;162(7):465–473. DOI: 10.7326/M14-1420
Friedly JL, Comstock BA, Turner JA, et al. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014;371(1):11–21. DOI: 10.1056/NEJMoa1313265